Nexus-BC: A Clinical Decision-Support Architecture
Research Title: Closing the Implementation Gap: A Trust-Centric Multimodal Agent for Breast Cancer Triage in Resource-Constrained and High-Density Tissue Populations.
1. The "Why": Analyzing the Implementation Gap
Research in early 2026 shows that 80% of healthcare AI projects fail to move past the pilot phase (HealthTech Digital, 2025). We have identified three specific "Chasms" your project will bridge:
The Data Reality Gap: Papers achieve 96%+ accuracy using "clean" datasets (like the curated 1.8M cases). In real-world clinics, images are often blurry or taken on decade-old hardware, causing accuracy to drop as low as 70% (Digital Health News, 2025).
The Confidence Crisis: Standard AI is "predominantly unimodal" and overconfident. It gives a score even if the image is unreadable. This leads to "False Comfort," where a woman ignores symptoms because a "perfect" AI gave her a green light (NIH/JMIR, 2025).
The Demographic Blind Spot: AI trained on Western datasets continues to miss 30% of cancers in dense-tissue populations (like South Asian youth) because it interprets glandular density as "noise" (Springer, 2025).
2. The Solution: Nexus-BC Multi-Agent System
Instead of a single "Black Box" model, we propose a Multi-Agent "Nervous System" for clinical workflows.
The Architecture (The "How"):
Bio-Logic Agent (Tabular): Analyzes clinical features (Age, Genetics, History) to establish a "Risk Baseline."
Vision-Agent (Imaging): A Swin Transformer that analyzes image patches independently, preventing the "smoothing out" of tiny tumors in dense tissue.
The Nexus (Decision Bridge): This is the Invention. It acts as a "Conflict Resolver." If the Bio-Agent says "High Risk" but the Vision-Agent sees "Normal," the system refuses to give a final score and triggers an automatic request for a supplemental Ultrasound or MRI.
3. The "Invention" Features for Publication
To be published in a top-tier journal, your project will introduce these three novelties:
Evidential Deep Learning: Your AI won't just say "Cancer/No Cancer." It will output a Confidence Interval. If the confidence is below 85%, it flags the case for "Immediate Human Review."
Density-Gated Attention: Following the 2025 Springer findings, the model will use the ACR Density Score to physically switch its internal mathematical filters to a higher-sensitivity mode for dense tissue.
Explainable Triage (XAI): Using Grad-CAM++ to show the doctor not just a "red dot," but a heatmap that correlates with the specific clinical risk factors (e.g., "Shadow detected here aligns with reported palpable lump location").
4. Technical Implementation Roadmap
Phase
Task
Data/Tooling
Phase 1: Stress Test
Audit standard AI models (ResNet/ViT) to prove they fail on "Low-Res" or "Dense" images.
Kaggle CBIS-DDSM / Duke MRI
Phase 2: Agent Dev
Build the Bio-Agent to identify high-risk young patients.
Python / TabNet
Phase 3: The Nexus
Create the Cross-Attention Bridge in PyTorch to link Bio + Vision.
MONAI / PyTorch
Phase 4: Trust Layer
Add OOD (Out-of-Distribution) Detection to catch blurry/bad images.
Bayesian Neural Networks5. Final "Safe" Reference Vault (2025-2026)
Use these to prove your project is solving the current 2026 problems:
The "Implementation Gap" (Aug 2025): Why 80% of Healthcare AI Fails - Use this to justify why you are building a "Decision Support System" instead of just a model.
Density & Asian Demographics (Springer 2025): Mammogram Density Trends Review - Use this to prove the "Density Layer" is a scientific priority.
The "Nature" AI-Stream Study (2025): Multicenter Prospective Cohort Study - Use this as your benchmark for success.
South Asian Clinical Model (2025): ResearchGate: Indian Population-Specific Risk Model - Use this for your clinical agent features.
